President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...

Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

WASHINGTON — Facing intense scrutiny from senators over his potential profit from vaccine lawsuits while serving as the ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV ...

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

In October, Merck said weak sales in China of its Gardasil vaccine, used to prevent HPV, were likely to continue into 2025 amid weak demand among women. China's drug regulator granted approval for ...

Jan 24 (Reuters) - Merck (MRK.N), opens new tab and Japan-based Eisai (4523.T), opens new tab said on Friday a combination of their therapies failed to extend the lives of patients with a type of ...

Merck (MRK) and Eisai (ESAIY) announced results from the Phase 3 LEAP-015 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, ...

Jan. 07, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ ... Through our collaborators at Merck, human trials to advance a novel vaccine candidate have now ...